suvorexant Articles

US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses

23 May 2013

FDA accepts Merck & Co's suvorexant; panel backs Novo's Tresiba and Ryzodeg

9 November 2012

Merck & Co's suvorexant improved patients' ability to fall asleep and stay asleep

14 June 2012

Merck & Co confirms NDA filing for suvorexant in 2012

7 February 2012

Merck & Co highlights pipeline progress; plans eight US filings in 2012-

11 November 2011

Showing 1-5 of 5 articles

Go to beginningPrevious
  • 1
NextGo to end